Showing results (341-350 of 413) with videos related to

Sort By:
Pageof 42
Molecular Cancer|July 22, 2025
An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trialAnton Lahusen, Manfred P Lutz, Rui Fang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 21, 2021
ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignanciesVincenzo Valentini, Francesco Cellini, Angela Riddell, et al.
Theranostics|March 15, 2019
A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic CancerAndreas W Berger, Daniel Schwerdel, Anke Reinacher-Schick, et al.
Endoscopy|February 6, 2019
Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) GuidelineCesare Hassan, Piotr Tomasz Wysocki, Lorenzo Fuccio, et al.
Oncotarget|November 22, 2014
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survivalSerena Lunardi, Nigel B Jamieson, Su Yin Lim, et al.
Gastroenterology|December 17, 2018
New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance StudiesLorenzo Fuccio, Douglas Rex, Thierry Ponchon, et al.
Plos One|June 14, 2024
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trialThomas Seufferlein, Ludwig Lausser, Alexander Stein, et al.
Pancreas|April 13, 2011
Inflammation, regeneration, and transformation in the pancreas: results of the Collaborative Research Center 518 (SFB 518) at the University of UlmKlaudia Giehl, Max Bachem, Michael Beil, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 28, 2025
DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic CancerDharini Srinivasan, Elodie Roger, Lukas Perkhofer, et al.
Clinical and Translational Science|November 3, 2023
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacyNicolas Hohmann, Martin Ronald Sprick, Moritz Pohl, et al.
Pageof 42